April 19, 2021

South Africa approves Pfizer vaccine for emergency use

The South African Health Products Regulatory Authority approved a section 21 emergency-use application for the Covid-19 vaccine developed by Pfizer and BioNTech.

The South African Health Products Regulatory Authority approved a section 21 emergency-use application for the Covid-19 vaccine developed by Pfizer and BioNTech.

Approval

SAHPRA made a statement that the approval was subject to further efficacy and safety testing, including testing against the dominant local Coronavirus variant.

The government has secured a total of 43 million doses through deals made with pharmaceutical companies Johnson & Johnson, Pfizer and Covax.

ALSO READ: Correctional services in KZN left shamed by sex video of prison guard and inmate

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: